Dajun Yang

CIK: 0002059751

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (20.0%)

Derivative conversions

Awards (A)8 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 21, 2026
Exercise(M)
Direct
95.6K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 21, 2026
Exercise(M)
Indirect
92.7K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Restricted stock units
Direct
95.6K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Restricted stock units
Direct
298.2K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Options
Direct
298.2K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Restricted stock units
Indirect
103.4K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Restricted stock units
Indirect
215K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Options
Indirect
215K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Options
Indirect
103.4K shares-
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
May 20, 2026
Award(A)
Restricted stock units
Indirect
92.7K shares-

		Type	Shares	Price		Ownership
May 21, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Exercise(M)	95,575	-	$0	Direct
May 21, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Exercise(M)	92,746	-	$0	Indirect
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Restricted stock units	95,575	-	-	Direct
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Restricted stock units	298,195	-	-	Direct
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Options	298,194	-	-	Direct
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Restricted stock units	103,365	-	-	Indirect
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Restricted stock units	214,999	-	-	Indirect
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Options	214,988	-	-	Indirect
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Options	103,364	-	-	Indirect
May 20, 2026	AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL	Award(A) Restricted stock units	92,746	-	-	Indirect

1-10 of 10 transactions

About Yang Dajun

Yang Dajun (SEC CIK 0002059751) files insider reports with the SEC as Chairman and CEO of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).

Signal8 holds 3 ownership filings by Yang Dajun (2 Form 3, 1 Form 4), filed between Mar 19, 2026 and May 22, 2026. Those filings report 10 transactions, from May 20, 2026 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Yang Dajun's filings is in ROCKVILLE, MD.

Recent filings by Yang Dajun

May 21, 2026: Option exercises of AAPG shares (2 lines, Form 4, code M).
May 20, 2026: Grants or awards of AAPG derivative securities (8 lines, Form 4, code A).

Other insiders filing for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)

Miyara Faical, Chief Business Officer
Zhai Yifan, Chief Medical Officer
Misra Veet, Chief Financial Officer
Cao Jin, Chief Accounting Officer
Wei Ren, Director
Ye Changqing, Director

How to read Form 4 transaction codes